JP
Jana Partners Portfolio holdings
AUM
$1.34B
This Quarter Return
+5.54%
1 Year Return
+5.03%
3 Year Return
+36.04%
5 Year Return
+55.17%
10 Year Return
+178.84%
AUM
$5.58B
AUM Growth
+$5.58B
(+17%)
Cap. Flow
+$698M
Cap. Flow
% of AUM
12.51%
Top 10 Holdings %
Top 10 Hldgs %
69.09%
Holding
65
New
16
Increased
7
Reduced
12
Closed
23
Top Buys
| 1 |
EQT Corp
EQT
|
$477M |
| 2 |
Zimmer Biomet
ZBH
|
$410M |
| 3 |
WFM
Whole Foods Market Inc
WFM
|
$379M |
| 4 |
P
Pandora Media Inc
P
|
$180M |
| 5 |
AABA
Altaba Inc. Common Stock
AABA
|
$180M |
Top Sells
| 1 |
Willis Towers Watson
WTW
|
$194M |
| 2 |
CSC
Computer Sciences
CSC
|
$187M |
| 3 |
AET
Aetna Inc
AET
|
$185M |
| 4 |
Universal Health Services
UHS
|
$133M |
| 5 |
YHOO
Yahoo Inc
YHOO
|
$117M |
Sector Composition
| 1 | Consumer Staples | 21.95% |
| 2 | Healthcare | 15.14% |
| 3 | Communication Services | 14.07% |
| 4 | Technology | 12.49% |
| 5 | Industrials | 8.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
QVCGA
51
QVC Group, Inc. Series A Common Stock
QVCGA
$65.8M
| – | – |
-2,956,230
| Closed | -$59.2M |
|
52
Financial Select Sector SPDR Fund
XLF
$53.6B
| – | – |
0
| – | – |
|
53
Energy Select Sector SPDR Fund
XLE
$27.1B
| – | – |
-57,180
| Closed | -$4M |
|
|
54
Willis Towers Watson
WTW
$31.9B
| – | – |
-1,478,952
| Closed | -$194M |
|
55
Snap
SNAP
$12.3B
| – | – |
-550,000
| Closed | -$12.4M |
|
56
Mattel
MAT
$5.87B
| – | – |
0
| – | – |
|
57
Laureate Education
LAUR
$4.12B
| – | – |
-285,500
| Closed | -$4.07M |
|
58
iShares Russell 2000 ETF
IWM
$66.6B
| – | – |
-22,000
| Closed | -$3.03M |
|
59
Home Depot
HD
$406B
| – | – |
0
| – | – |
|
60
GE Aerospace
GE
$293B
| – | – |
0
| – | – |
|
61
Bristol-Myers Squibb
BMY
$96.7B
| – | – |
-716,389
| Closed | -$39M |
|
62
BioMarin Pharmaceuticals
BMRN
$11.3B
| – | – |
-92,030
| Closed | -$8.08M |
|
63
Bread Financial
BFH
$3.07B
| – | – |
-426,037
| Closed | -$106M |
|
64
Acadia Pharmaceuticals
ACAD
$4.34B
| – | – |
-421,140
| Closed | -$14.5M |
|
65
AbbVie
ABBV
$374B
| – | – |
0
| – | – |
|